GHK-Cu serum checklist: how to read a copper peptide label

Prepared by: Research Desk. Sources are linked for verification.

Copper peptide serums now fill a whole shelf at most beauty retailers. Their marketing ranges from careful to wildly overstated. The label is the one part of a product that is shaped by regulation. Under U.S. law, what a product is intended to do decides whether it is regulated as a cosmetic or as a drug, and that intent is shown largely through the claims made for it [1].

This guide is for formulators benchmarking competitor products and for readers comparing a GHK-Cu serum on paper before purchase. It covers four things: how to find the ingredient on an INCI list, which stability questions copper chemistry raises, which packaging details are worth noticing, and how to spot claims that cross the cosmetic/drug line. It does not rank products, give usage instructions or promise any skin outcome. For the underlying science, see our evidence for GHK-Cu by study type.

Why the label matters more than the marketing

Product pages, influencer videos and retailer blurbs exist to persuade. The label and the company's official claims are where accountability sits. The FDA notes that intended use can be established by claims on the label, but also by claims in advertising, on websites and on social media. Consumer perception can play a role too, and so can ingredients with a well-known therapeutic use [1]. A serum with a modest label but an aggressive brand website is still making those website claims.

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) added duties for cosmetic companies. These include facility registration, product listing, reporting of serious adverse events, and keeping records that substantiate product safety. MoCRA also requires cosmetic labels to carry contact information through which adverse events can be reported [2]. None of these duties amounts to FDA approval. Still, a label that clearly identifies a responsible company and gives a working contact route signals a brand that expects to be held to these rules.

Finding GHK-Cu on an INCI list

Ingredient lists use INCI (International Nomenclature of Cosmetic Ingredients) names, not marketing names. The entries worth recognising:

• Copper Tripeptide-1. This is the INCI name usually used on labels for the GHK-copper complex. That complex is the form most of the published research describes [3][4].

• Tripeptide-1 listed next to a separate copper salt. The label alone does not show whether the two are intended to form a complex in the finished formula. That is a question for the brand.

• Other "tripeptide" names (for example Palmitoyl Tripeptide-1). These are separate INCI entries. Rather than assume equivalence with Copper Tripeptide-1, request the supplier's specification for each.

• Copper salts on their own (for example copper gluconate). A copper source is not the same entry as the copper tripeptide.

• Trade names and "copper peptide complex". A proprietary blend name means little without the INCI names underneath it.

Two caveats apply. First, an ingredient list shows identity, not concentration. A percentage printed on the front of a bottle is a marketing claim that the list cannot verify. Second, a brand that publishes how it confirms ingredient identity and content offers more than one that only states a number.

Copper chemistry and formula stability: questions to put to a brand

GHK's defining chemical feature is its high affinity for copper(II) ions, and that binding is what makes GHK-Cu a distinct ingredient [3]. A finished formula therefore has to keep copper associated with the peptide through manufacturing and storage. Few brands publish stability data, so the useful move is knowing which questions an ingredient list raises. The points below are framed as questions, not verdicts.

pH. What pH range does the raw-material supplier specify for the complex, and does the finished product sit inside it? A formula built around strong exfoliating acids is a reasonable prompt to request finished-product stability data.

Chelators. Ingredients sold as chelators (EDTA salts, for instance) are added to bind metal ions. In a copper product, it is fair to ask whether stability testing looked at their effect on copper binding. Their presence is not automatically a defect.

Active pairings. Combinations such as copper peptides with vitamin C appear often. The neutral question is whether the brand tested that combination for stability, and whether it will share the results.

Carrier logic. In the classification proposed by Gorouhi and Maibach, GHK-Cu is a carrier peptide: its proposed role is delivering copper, a cofactor for enzymes involved in matrix and antioxidant processes [5]. That framing is why copper availability, not only peptide presence, matters when judging a formula on paper.

Packaging, appearance and storage clues

• Appearance over time. A noticeable change in a serum's color or clarity during storage is worth raising with the brand. Only analytical testing can establish what changed.

• Light and air protection. Opaque or UV-protective containers and airless pumps limit exposure to light and oxygen. Open droppers allow more air contact and repeated handling.

• Lot number and dating. A printed lot code, plus an expiry date or period-after-opening symbol, shows traceability and a defined shelf life.

• Responsible company details. A named company, an address and an adverse-event contact route reflect MoCRA's labelling expectations [2].

• Price transparency. Compare price per unit volume, not per bottle, because bottle sizes vary widely.

Cosmetic claims versus drug-style claims

The FDA defines cosmetics by uses such as cleansing, beautifying, promoting attractiveness or altering the appearance. Drugs are products intended for use against disease, or intended to affect the structure or any function of the body. A product can be both, and when it is, it must meet the drug requirements, including drug-style labelling of active ingredients [1].

This line matters more for copper peptides than for most ingredients. Much of the GHK-Cu literature concerns wound repair and tissue remodeling [3][4]. Brands that repeat those findings in marketing can turn a cosmetic into an unapproved drug in regulatory terms. Our explainer on cosmetic versus drug rules for copper peptides covers this in depth, including the separate status of injectable forms.

Other warning signs:

• "FDA-approved" on a cosmetic. The FDA does not pre-approve cosmetic products, so the phrase has no meaning there [1][2].

• "Medical-grade" or "pharmaceutical-grade." These are marketing phrases, not a cosmetic category in the FDA's definitions [1].

• Gene claims. Gene-expression findings for GHK come from analyses of cell-line datasets [4]. Presenting them as proof that a cream rewrites gene activity in skin overstates what was measured.

• No company contact route for adverse-event reports [2].

A drug-style claim says nothing direct about formula quality. It does say something about how carefully a brand handles the rules, which is a useful proxy for how carefully it handles the rest of its documentation.

What the evidence does and does not support

Most GHK-Cu research is preclinical. Reviews by Pickart and colleagues summarise cell and animal findings on matrix remodeling, antioxidant activity and cell signalling, and describe small controlled studies of facial creams in human volunteers [3]. The 2018 gene-data review extends this with computational analyses of expression datasets [4]. These are hypothesis-generating results, not demonstrations in human skin.

Two limits are worth stating plainly. First, much of the foundational review literature is authored by Pickart and collaborators [3][4], and the summaries do not always give enough detail to judge study size, blinding or sponsorship. Tracing claims back to the original studies is worthwhile. Second, the independent review by Gorouhi and Maibach found the evidence base for cosmetic peptides generally limited by small trials and few head-to-head comparisons [5].

So no label can tell a reader what a serum will do. The criteria in this guide judge transparency, chemistry questions and compliance. They do not measure outcomes.

A printable evaluation checklist

Ingredient identity

- [ ] Copper Tripeptide-1 appears on the INCI list, or the copper source and Tripeptide-1 are both listed and explained

- [ ] Other "tripeptide" names or a lone copper salt are not presented as the same ingredient

- [ ] Any front-label percentage comes with a stated method of verification

Chemistry and stability

- [ ] Chelators present? Note them and look for stability evidence

- [ ] Multiple actives combined? Note the pairing and look for compatibility data

- [ ] The brand publishes or supplies stability data on request

Packaging and traceability

- [ ] Light-protective container; airless pump noted

- [ ] Lot code plus expiry date or period-after-opening symbol

- [ ] Named responsible company with an adverse-event contact route

Claims

- [ ] Wording describes appearance, not repair, regrowth or disease

- [ ] No "FDA-approved", "medical-grade" or gene-reset language

- [ ] Study claims name the study size and design, and disclose sponsorship

Value

- [ ] Price per unit volume calculated and compared

- [ ] Return policy and full ingredient list visible on the retailer listing

Tools and further reading

When comparing serums at major beauty retailers, use the checklist above alongside each listing. Look for the full ingredient list, lot and dating details, return terms and the unit price. Brands that answer formulation questions in writing make comparison far easier.

How paid links on this site are labelled, and how we source our pages, is set out on our about this site page.

Last updated: 18 October 2026.

Not medical advice. This page reports published research and regulatory records for information only.

Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.

Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.